...
首页> 外文期刊>Cancer Cell International >LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1
【24h】

LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1

机译:LNCRNA KCNQ1OT1海绵MIR-15A通过Up-Consemate PD-L1促进前列腺癌的免疫逃避和恶性进展

获取原文
           

摘要

We focused on the KCNQ1OT1/miR-15a/PD-L1 axis and explored its significance in regulating immune evasion and malignant behaviors of prostate cancer (PC) cells. The expression levels of KCNQ1OT1, miR-15a, PD-L1, and CD8 in cells or tissues were examined by RT-qPCR, western blot or immunohistochemistry (IHC) assays. The direct regulations between KCNQ1OT1, miR-15a and PD-L1 were validated by luciferase reporter assay. PC cells were co-cultured with CD8 T cells to study the immune evasion. Proliferation, apoptosis, migration and invasion abilities were detected by MTT, flow cytometry, wound healing and Transwell assays, respectively. The cytotoxicity of CD8 T cells was determined by LDH cytotoxicity Kit. Epithelial–mesenchymal transition (EMT) and Ras/ERK signaling markers were evaluated by western blot. KCNQ1OT1, PD-L1 and CD8 were increased, while miR-15a was decreased in PC tissues. MiR-15a directly bound to the 3′-UTR of PD-L1 and inhibited the expression of PD-L1. Overexpressing miR-15a in PC cells was sufficient to promote cytotoxicity and proliferation, while inhibit apoptosis of CD8 T cells, and also suppressed viability, migration, invasion and EMT while promoted apoptosis of PC cells. The above anti-tumor effects of miR-15a were reversed by overexpressing PD-L1. KCNQ1OT1 sponged miR-15a and released its inhibition on PD-L1. Functionally, KCNQ1OT1 in PC cells was essential for suppressing the cytotoxicity of CD8 T cells and maintaining multiple malignant phenotypes of PC cells. The Ras/ERK signaling was suppressed after overexpressing miR-15a or knocking down KCNQ1OT1. LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of PC via up-regulating PD-L1.
机译:我们专注于KCNQ1OT1 / miR-15A / PD-L1轴,并探讨了调节前列腺癌(PC)细胞的免疫逃避和恶性行为的重要性。通过RT-QPCR,Western印迹或免疫组织化学(IHC)测定,检查KCNQ1OT1,miR-15a,pd-L1和CD8中的表达水平。通过Luciferase报道测定验证KCNQ1OT1,MIR-15A和PD-L1之间的直接规则。将PC细胞与CD8 T细胞共同培养,以研究免疫逃逸。通过MTT,流式细胞术,伤口愈合和Transwell测定来检测增殖,细胞凋亡,迁移和侵袭能力。 CD8 T细胞的细胞毒性由LDH细胞毒性试剂盒测定。通过Western印迹评估上皮 - 间充质转换(EMT)和RAS / ERK信号标记。 kcnq1ot1,pd-l1和cd8增加,而miR-15a在PC组织中降低。 miR-15a直接与PD-L1的3'-UTR结合并抑制PD-L1的表达。在PC细胞中过度抑制miR-15a足以促进细胞毒性和增殖,同时抑制CD8 T细胞的凋亡,以及抑制了促进PC细胞凋亡的生存能力,迁移,侵袭和EMT。通过过表达PD-L1反转miR-15a的上述抗肿瘤作用。 KCNQ1OT1海绵状miR-15a并释放其对PD-L1的抑制作用。在功能上,PC细胞中的KCNQ1OT1对于抑制CD8 T细胞的细胞毒性并保持多种PC细胞的恶性表型,这是必不可少的。在过表达miR-15a或敲下kcnq1ot1后,抑制了Ras / ERK信号传导。 LNCRNA KCNQ1OT1海绵MIR-15A通过UP-Chanding PD-L1促进PC的免疫逃逸和恶性进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号